FDA does not approve new Alzheimer’s drug

Alzheimer; News from the web:

Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.

The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to show “strong evidence” that the drug worked. The experts warned of multiple “red flags” with the data, which did not initially show any benefit until another analysis with later results.

Read all about it HERE

First Alzheimer’s Blood Test Rolled Out for Clinical Use in US

Alzheimer; News from the web:

The first blood test designed to assist physicians in determining whether a patient has Alzheimer’s disease is now available in most US states, the company C2N Diagnostics announced October 29. The test measures biomarkers that frequently reflect the presence of amyloid plaques in the brain—a hallmark of Alzheimer’s—as well as the presence of a gene variant that increases the risk of the disease.

Read all about it HERE

About sleep and Alzheimer’s

Alzheimer; News from the web:

We know that people with Alzheimer’s often have sleep problems. But does it work the other way? Do problems with sleep set the stage for this degenerative brain disease?

NPR.org

Read all about it HERE